Skip to main content
. Author manuscript; available in PMC: 2018 Mar 14.
Published in final edited form as: Ann Rheum Dis. 2016 Jun 13;76(1):186–195. doi: 10.1136/annrheumdis-2016-209252

Table 2.

Characteristics of study participants and association of baseline biomarker concentrations with covariates for the whole cohort

Covariates Comparators (n=406) Cases (n=194) Biomarker associations with covariates*
Age, mean years (SD) 61.3 (8.9) 62.0 (8.8) sCOMP, sHA, sMMP3, uC2C-HUSA, uC1, 2C, uCTXII
Sex, n (%) female 243 (60%) 110 (57%) sC1, 2C, sCS846, sCTXI, s+uNTXI, sMMP3, uCol2-1 NO2, uC1, 2C, uC2C-HUSA, uCTXII, uCTXIα, uCTXIβ
BMI, mean kg/m2 (SD) 30.7 (4.8) 30.7 (4.8) sCTXI, sMMP3, sPIIANP, uNTXI, uCTXIα
History of knee injury, n (%) yes 145 (36%) 68 (35%)
Baseline knee Kellgren-Lawrence grade, n (%)
  KL1 51 (13%) 24 (12%)
  KL2 222 (55%) 84 (43%)
  KL3 133 (33%) 86 (44%)
White race, n (%) 320 (79%) 1 55 (80%) sC1, 2C, s+uCol2-1 NO2, sCTXI, sHA, uC2C-HUSA
Baseline use of pain medication, n (%) yes 114 (28%) 63 (32%) sCPII, uCol2-1 NO2, uCTXII, uNTXI, uCTXIα
Baseline WOMAC pain score, mean (SD) 13.0 (16.7) 10.2 (13.0) sPIIANP, uCTXII
Baseline joint space width, mean mm (SD) 3.9 (1.1) 3.8 (1.4) sHA, uC2C-HUSA
*

Detailed results of associations of biomarkers with covariates are provided in online supplementary table S2.

WOMAC, Western Ontario and McMaster Universities Arthritis Index.